| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.55B | 47.08B | 51.51B | 50.90B | 59.51B | 37.51B |
| Gross Profit | 7.69B | 9.99B | 9.20B | 9.22B | 12.19B | 6.09B |
| EBITDA | 6.36B | 6.83B | 8.24B | 8.27B | 11.28B | 5.23B |
| Net Income | 2.92B | 3.27B | 4.79B | 4.89B | 7.34B | 2.48B |
Balance Sheet | ||||||
| Total Assets | 45.45B | 42.31B | 42.94B | 41.20B | 43.52B | 40.78B |
| Cash, Cash Equivalents and Short-Term Investments | 1.03B | 1.14B | 979.00M | 864.00M | 3.75B | 2.15B |
| Total Debt | 4.14B | 4.38B | 4.16B | 4.33B | 4.43B | 5.42B |
| Total Liabilities | 22.70B | 20.05B | 19.46B | 18.98B | 21.11B | 19.05B |
| Stockholders Equity | 22.75B | 22.25B | 23.47B | 22.22B | 22.41B | 21.73B |
Cash Flow | ||||||
| Free Cash Flow | 3.85B | 4.70B | 4.11B | 1.95B | 8.96B | 4.37B |
| Operating Cash Flow | 5.94B | 6.71B | 5.98B | 3.73B | 10.48B | 5.48B |
| Investing Cash Flow | -1.97B | -1.89B | -1.82B | -1.69B | -618.00M | -1.01B |
| Financing Cash Flow | -4.71B | -4.65B | -4.04B | -4.92B | -8.27B | -3.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | C$78.12B | 11.02 | 15.23% | 3.40% | -10.01% | 67.09% | |
76 Outperform | C$110.41B | 13.02 | 14.01% | 3.91% | 0.86% | 8.90% | |
73 Outperform | C$62.98B | 125.98 | 9.47% | 0.19% | 7.48% | 161.48% | |
71 Outperform | C$88.93B | 23.48 | 13.43% | 2.45% | -7.49% | -37.07% | |
71 Outperform | C$101.94B | 24.46 | 12.53% | 4.41% | 1.37% | -24.17% | |
70 Outperform | C$140.26B | 26.23 | 22.74% | 5.23% | 0.74% | 29.91% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% |